These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 24429946

  • 1. [Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy].
    Avakian GN, Oleĭnikova OM, Lagutin IuV, Khromykh EA, Bogomazova MA, Delger AB, Avakian GG.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):34-9. PubMed ID: 24429946
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
    Stockis A, Sargentini-Maier ML, Brodie MJ.
    Epilepsy Res; 2016 Dec; 128():163-168. PubMed ID: 27842261
    [Abstract] [Full Text] [Related]

  • 3. Lack of interaction of gabapentin with carbamazepine or valproate.
    Radulovic LL, Wilder BJ, Leppik IE, Bockbrader HN, Chang T, Posvar EL, Sedman AJ, Uthman BM, Erdman GR.
    Epilepsia; 1994 Dec; 35(1):155-61. PubMed ID: 8112239
    [Abstract] [Full Text] [Related]

  • 4. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C, De Smedt H, Stockis A.
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [Abstract] [Full Text] [Related]

  • 5. Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy.
    Suemaru K, Kawasaki H, Yasuhara K, Yao K, Furuno K, Kawakami Y, Araki H, Gomita Y, Oka E.
    Acta Med Okayama; 1998 Jun; 52(3):139-42. PubMed ID: 9661740
    [Abstract] [Full Text] [Related]

  • 6. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B, Galas-Zgorzalewicz B.
    Folia Neuropathol; 2002 Jun; 40(2):97-100. PubMed ID: 12230261
    [Abstract] [Full Text] [Related]

  • 7. Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers.
    Vaz J, Kulkarni C, David J, Joseph T.
    Indian J Exp Biol; 1998 Jan; 36(1):112-4. PubMed ID: 9536660
    [Abstract] [Full Text] [Related]

  • 8. Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group.
    Prevey ML, Delaney RC, Cramer JA, Cattanach L, Collins JF, Mattson RH.
    Arch Neurol; 1996 Oct; 53(10):1008-16. PubMed ID: 8859063
    [Abstract] [Full Text] [Related]

  • 9. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients].
    Chen ZJ, Wang XD, Zhou LM, Fang ZY, Wang HS, Li JL, Zhou JQ, Huang HB, Huang M.
    Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473
    [Abstract] [Full Text] [Related]

  • 10. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
    El Desoky E, Kandil MR, Afifi AH, Mostafa OA.
    Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
    [Abstract] [Full Text] [Related]

  • 11. Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients.
    Shakir S, Ali N, Nazish H.
    J Coll Physicians Surg Pak; 2018 May; 28(5):357-360. PubMed ID: 29690963
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G, Malla S, Shakya KN, Shrestha R.
    JNMA J Nepal Med Assoc; 2008 May; 47(171):94-7. PubMed ID: 19079370
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic concentration of antiepileptic drugs and the severity of epileptogenesis.
    Seino M, Kakegawa N.
    Electroencephalogr Clin Neurophysiol Suppl; 1982 May; 36():438-46. PubMed ID: 6819123
    [Abstract] [Full Text] [Related]

  • 14. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
    Kong ST, Lim SH, Chan E, Ho PC.
    J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM, Jovanovic D, Milovanovic JR.
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetic aspects of carbamazepine and valproic acid using in reproductive-age women with epilepsy].
    Karlov VA, Vlasov PN, Sokolov AV, Tishchenkova IF.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002 Nov; 102(1):37-41. PubMed ID: 11842620
    [Abstract] [Full Text] [Related]

  • 17. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy.
    Juárez-Olguín H, Lugo-Goytia G, Flores-Murrieta F, Ruiz-García M, Lares Asseff I, Flores Pérez J.
    Rev Invest Clin; 2010 Nov; 62(6):516-23. PubMed ID: 21416779
    [Abstract] [Full Text] [Related]

  • 18. A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy.
    Iivanainen M, Waltimo O, Tokola O, Parantainen J, Tamminen M, Allonen H, Neuvonen PJ.
    Acta Neurol Scand; 1990 Aug; 82(2):121-5. PubMed ID: 2124033
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
    Fakhoury TA, Hammer AE, Vuong A, Messenheimer JA.
    Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
    [Abstract] [Full Text] [Related]

  • 20. Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy.
    Lenn NJ, Robertson M.
    Neurology; 1992 May; 42(5):988-90. PubMed ID: 1579255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.